Niloufar Mohammadkhani
- Co-authors
- Mehdi ShakibaeiAnna‐Lena MuellerZahra PayandehAranka BrockmuellerAlireza ZakeriArmina Alagheband BahramiHuda Fatima RajaniSaeedeh Nouri-Majd
- Topics
- CAR-T cell therapy research (2 papers)Immunotherapy and Immune Responses (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)
In The Last Decade
Niloufar Mohammadkhani
11 papers receiving 463 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Molecular Biology 190
- Oncology 100
- Immunology 89
- Rheumatology 85
- Cancer Research 66
Countries citing papers authored by Niloufar Mohammadkhani
This map shows the geographic impact of Niloufar Mohammadkhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niloufar Mohammadkhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niloufar Mohammadkhani more than expected).
Fields of papers citing papers by Niloufar Mohammadkhani
This network shows the impact of papers produced by Niloufar Mohammadkhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niloufar Mohammadkhani. The network helps show where Niloufar Mohammadkhani may publish in the future.
Co-authorship network of co-authors of Niloufar Mohammadkhani
This figure shows the co-authorship network connecting the top 25 collaborators of Niloufar Mohammadkhani. A scholar is included among the top collaborators of Niloufar Mohammadkhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niloufar Mohammadkhani. Niloufar Mohammadkhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 19 | |
| 3 | 6 | |
| 4 | Naringenin: A potential flavonoid phytochemical for cancer therapybreakdown → | 179 |
| 5 | 12 | |
| 6 | 10 | |
| 7 | Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategiesbreakdown → | 152 |
| 8 | 1 | |
| 9 | 40 | |
| 10 | 10 | |
| 11 | 24 |
About Niloufar Mohammadkhani
Niloufar Mohammadkhani is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 11 papers that have together received 467 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Rheumatology (85 citations), Cancer Research (66 citations) and Immunology (89 citations). Niloufar Mohammadkhani has collaborated with scholars based in Iran, Germany and Canada. Frequent co-authors include Mehdi Shakibaei, Anna‐Lena Mueller, Zahra Payandeh, Aranka Brockmueller, Alireza Zakeri, Armina Alagheband Bahrami, Huda Fatima Rajani, Saeedeh Nouri-Majd, Francisco Veiga and Ana Cláudia Paiva‐Santos. Their work appears in journals such as Molecules, Life Sciences and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.